Download This Bill in Microsoft Word format

R218, H4617

STATUS INFORMATION

General Bill
Sponsors: Reps. Hixon, Davis, M.M. Smith, Bannister, Pope, Wooten, Haddon, Brewer, Burns, Thayer, Kirby, Oremus, Hager, Hyde, Sessions, Carter, McDaniel, Magnuson, Hayes, W. Newton, Bauer, Trantham, J.L. Johnson, Henegan, Guffey, Chapman, Leber, Kilmartin, Robbins, Felder, Jefferson, Caskey, Ligon and Vaughan
Companion/Similar bill(s): 849
Document Path: LC-0314VR24.docx

Introduced in the House on January 9, 2024
Introduced in the Senate on January 16, 2024
Last Amended on May 8, 2024
Currently residing in the House
Governor's Action: May 20, 2024, Signed

Summary: Xylazine

HISTORY OF LEGISLATIVE ACTIONS

Date	Body	Action Description with journal page number
11/16/2023	House	Prefiled
11/16/2023	House	Referred to Committee on Medical, Military, Public and Municipal Affairs
1/9/2024	House	Introduced and read first time (House Journal-page 100)
1/9/2024	House	Referred to Committee on Medical, Military, Public and Municipal Affairs (House Journal-page 100)
1/9/2024	House	Member(s) request name added as sponsor: Kilmartin
1/10/2024	House	Member(s) request name added as sponsor: Robbins, Felder
1/10/2024	House	Committee report: Favorable Medical, Military, Public and Municipal Affairs (House Journal-page 1)
1/11/2024	House	Member(s) request name added as sponsor: Jefferson, Caskey, Ligon, Vaughan
1/11/2024	House	Read second time (House Journal-page 15)
1/11/2024	House	Roll call Yeas-103 Nays-0 (House Journal-page 15)
1/11/2024	House	Unanimous consent for third reading on next legislative day (House Journal-page 17)
1/12/2024	House	Read third time and sent to Senate (House Journal-page 1)
1/16/2024	Senate	Introduced and read first time (Senate Journal-page 4)
1/16/2024	Senate	Referred to Committee on Judiciary (Senate Journal-page 4)
1/19/2024	Senate	Referred to Subcommittee: Hutto (ch), Rice, Senn, Adams, Tedder
5/1/2024	Senate	Committee report: Favorable with amendment Judiciary (Senate Journal-page 12)
5/8/2024	Senate	Committee Amendment Adopted (Senate Journal-page 145)
5/8/2024	Senate	Read second time (Senate Journal-page 145)
5/8/2024	Senate	Roll call Ayes-44 Nays-0 (Senate Journal-page 145)
5/9/2024	Senate	Read third time and returned to House with amendments (Senate Journal-page 125)
5/9/2024	House	Concurred in Senate amendment and enrolled (House Journal-page 106)
5/9/2024	House	Roll call Yeas-104 Nays-0 (House Journal-page 107)
5/15/2024		Ratified R 218
5/20/2024		Signed By Governor
5/29/2024		Effective date 05/20/24
5/29/2024		Act No. 177

View the latest legislative information at the website

VERSIONS OF THIS BILL

11/16/2023
01/10/2024
05/01/2024
05/08/2024

NOTE: THIS IS A TEMPORARY VERSION. THIS DOCUMENT WILL REMAIN IN THIS VERSION UNTIL FINAL APPROVAL BY THE LEGISLATIVE COUNCIL.

(A177, R218, H4617)

AN ACT TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY AMENDING SECTION 44-53-230, RELATING TO SCHEDULE III CONTROLLED SUBSTANCES, SO AS TO ADD XYLAZINE AS A SCHEDULE III CONTROLLED SUBSTANCE; BY ADDING SECTION 44-53-372 SO AS TO PROHIBIT THE PRODUCTION, MANUFACTURE, DISTRIBUTION, OR POSSESSION OF XYLAZINE, WITH EXCEPTIONS, AND TO ESTABLISH ASSOCIATED CRIMINAL PENALTIES; AND BY ADDING SECTION 44-53-373 SO AS TO CREATE AN EXCEPTION FOR VETERINARY USE OF XYLAZINE.

Be it enacted by the General Assembly of the State of South Carolina:

Schedule III controlled substances

SECTION 1.    Section 44-53-230(c) of the S.C. Code is amended by adding:

13. Xylazine.

Prohibited acts, xylazine

SECTION 2.    Article 3, Chapter 53, Title 44 of the S.C. Code is amended by adding:

Section 44-53-372.    (A)(1) It is unlawful for any person to knowingly or intentionally produce, manufacture, distribute, or possess with intent to produce, manufacture, or distribute xylazine for a use other than a nonhuman use.

(2) A person who violates the provisions of this subsection is guilty of a felony and, upon conviction, must be imprisoned not more than ten years or fined not more than fifteen thousand dollars, or both.

(B)(1) It is unlawful for any person to knowingly or intentionally possess xylazine.

(2) A person who violates the provisions of this subsection is guilty of a misdemeanor and, upon conviction, must be imprisoned not more than one hundred eighty days or fined not more than five hundred dollars, or both.

(C) The provisions of this section do not apply to any of the following:

(1) the production, manufacturing, distribution, or possession of xylazine for use in legitimate veterinary practice;

(2) the production, manufacturing, distribution, or possession of a xylazine bulk chemical for pharmaceutical compounding by a licensed pharmacist or veterinarian for use in a nonhuman species;         (3) the possession of xylazine pursuant to a valid prescription from a licensed veterinarian for use in a nonhuman species; or

(4) the possession of xylazine in an injectable form for use in a nonhuman species.

(D) For purposes of this section, "xylazine" means xylazine and any salt, sulfate, isomer, homologue, analogue, or other preparation of xylazine, and any salt, isomer, compound, derivative, precursor, homologue, analogue, or other preparation thereof that is substantially chemically equivalent or identical to xylazine.

Xylazine, authorized uses

SECTION 3.    Chapter 53, Title 44 of the S.C. Code is amended by adding:

Section 44-53-373.    Nothing in this article applies to veterinarians in connection with the practice of their profession and the legitimate use of xylazine within the veterinary practice, including:

(A) the distribution or possession of xylazine by a licensed veterinarian for use in legitimate veterinary practice;

(B) the possession of xylazine pursuant to a valid prescription from a licensed veterinarian; or

(C) the possession of xylazine in an injectable form for use in nonhuman species.

Time effective

SECTION 4.    This act takes effect upon approval by the Governor.

Ratified the 15th day of May, 2024.

Approved the 20th day of May, 2024.

This web page was last updated on May 29, 2024 at 2:56 PM